Efficacy and Safety of High-Dose versus Low-dose methylprednisolone pulse therapy for IgA vasculitis Nephritis: a retrospective observational study
This retrospective observational study of 122 pediatric patients with IgA vasculitis nephritis and limited crescent formation found that while high-dose methylprednisolone pulse therapy achieved faster clinical remission and higher response rates at 1 and 3 months compared to low-dose therapy, both regimens demonstrated comparable long-term efficacy at 6 and 12 months, with the high-dose approach carrying a significantly higher risk of adverse reactions.